Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FU.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HH.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.22.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.22.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.22.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.22.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.22.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.22.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GY.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GY.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GY.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FE.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FE.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FE.1.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FE.1.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FE.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used